Clinical risk stratification: Prague validation of the DAAE score, a clinical tool for estimating risk of disesase progression in multiple sclerosis
Julia R. Jelgerhuis(Amsterdam Neuroscience), Tom Fuchs(Amsterdam Neuroscience), Tomáš Uher(Charles University), Menno M. Schoonheim(Amsterdam Neuroscience), Eva Havrdová(Charles University), Dana Horáková(Charles University)
Cited by 2
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
Loss of ‘Small-World’ Networks in Alzheimer's Disease: Graph Analysis of fMRI Resting-State Functional Connectivity
|PLoS ONE|2010|621
Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment
|Neurobiology of Aging|2011|396
Sleep benefits subsequent hippocampal functioning
|Nature Neuroscience|2009|314